{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:13:22Z","timestamp":1760782402106},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Renal Replacement Therapy"],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1053\/jarr.2002.34845","type":"journal-article","created":{"date-parts":[[2002,8,29]],"date-time":"2002-08-29T19:51:36Z","timestamp":1030650696000},"page":"168-174","source":"Crossref","is-referenced-by-count":21,"title":["Vitamin D receptor\u2013mediated gene regulation mechanisms and current concepts of vitamin D analog selectivity"],"prefix":"10.1053","volume":"9","author":[{"given":"J.Wesley","family":"Pike","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirupama K.","family":"Shevde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/jarr.2002.34845_NEWBIB1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","article-title":"The nuclear receptor superfamily: the second decade","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"key":"10.1053\/jarr.2002.34845_NEWBIB2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1210\/edrv-11-2-201","article-title":"Steroid receptor family: Structure and functions","volume":"11","author":"Carson-Jurica","year":"1990","journal-title":"Endocr Rev"},{"key":"10.1053\/jarr.2002.34845_NEWBIB3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1095\/biolreprod46.2.163","article-title":"Molecular pathways of steroid receptor action","volume":"46","author":"O'Malley","year":"1992","journal-title":"Biol Reprod"},{"key":"10.1053\/jarr.2002.34845_NEWBIB4","first-page":"321","article-title":"Nuclear receptor coregulators: Cellular and molecular biology","volume":"20","author":"Onate","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1053\/jarr.2002.34845_NEWBIB5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0960-0760(00)00108-4","article-title":"Estrogen receptor pathways to AP-1","volume":"74","author":"Kushner","year":"2000","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1053\/jarr.2002.34845_NEWBIB6","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1038\/sj.onc.1204388","article-title":"Cross-talk between glucocorticoid receptor and AP-1","volume":"20","author":"Herrlich","year":"2001","journal-title":"Oncogene"},{"key":"10.1053\/jarr.2002.34845_NEWBIB7","first-page":"435","article-title":"Molecular control of immune\/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways","volume":"20","author":"McKay","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1053\/jarr.2002.34845_NEWBIB8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0083-6729(01)62006-5","article-title":"Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions","volume":"62","author":"Safe","year":"2001","journal-title":"Vitam Horm"},{"key":"10.1053\/jarr.2002.34845_NEWBIB9","doi-asserted-by":"crossref","first-page":"25322","DOI":"10.1074\/jbc.M002497200","article-title":"Mutations in the estrogen receptor ligand binding domain discriminate between hormone-dependent transactivation and transrepression","volume":"275","author":"Valentine","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1053\/jarr.2002.34845_NEWBIB10","first-page":"119","article-title":"Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones","volume":"10","author":"Katzenellenbogen","year":"1996","journal-title":"Mol Endocrinol"},{"key":"10.1053\/jarr.2002.34845_NEWBIB11","first-page":"1953","article-title":"Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: Requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains","volume":"15","author":"Metivier","year":"2001","journal-title":"Mol Endocrinol"},{"key":"10.1053\/jarr.2002.34845_NEWBIB12","doi-asserted-by":"crossref","first-page":"19513","DOI":"10.1016\/S0021-9258(18)41805-4","article-title":"Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation","volume":"267","author":"Allan","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1053\/jarr.2002.34845_NEWBIB13","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1073\/pnas.96.7.3999","article-title":"Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta","volume":"96","author":"Paige","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/jarr.2002.34845_NEWBIB14","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0092-8674(00)81717-1","article-title":"The structural basis of estrogen receptor\/coactivator recognition and the antagonism of this interaction by tamoxifen","volume":"95","author":"Shiau","year":"1998","journal-title":"Cell"},{"key":"10.1053\/jarr.2002.34845_NEWBIB15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1042\/bst0260054","article-title":"Definition of the molecular mechanism of action of tissue-selective oestrogen-receptor modulators","volume":"26","author":"McDonnell","year":"1998","journal-title":"Biochem Soc Trans"},{"key":"10.1053\/jarr.2002.34845_NEWBIB16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1043-2760(99)00183-6","article-title":"Evolving concepts of selective estrogen receptor action: From basic science to clinical applications","volume":"10","author":"Smith","year":"1999","journal-title":"Trends Endocrinol Metab"},{"key":"10.1053\/jarr.2002.34845_NEWBIB17","first-page":"1177","article-title":"Selective estrogen-receptor modulators in 2001","volume":"15","author":"O'Regan","year":"2001","journal-title":"Oncology (Huntingt)"},{"key":"10.1053\/jarr.2002.34845_NEWBIB18","first-page":"5","article-title":"Evaluation and treatment of postmenopausal osteoporosis","volume":"7","author":"Wang","year":"2001","journal-title":"Am J Manag Care"},{"key":"10.1053\/jarr.2002.34845_NEWBIB19","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/39645","article-title":"Molecular basis of agonism and antagonism in the oestrogen receptor","volume":"389","author":"Brzozowski","year":"1997","journal-title":"Nature"},{"key":"10.1053\/jarr.2002.34845_NEWBIB20","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/79637","article-title":"An issue of tissues: Divining the split personalities of selective estrogen receptor modulators","volume":"6","author":"McKenna","year":"2000","journal-title":"Nat Med"},{"key":"10.1053\/jarr.2002.34845_NEWBIB21","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1210\/mend.11.9.9979","article-title":"Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo","volume":"11","author":"Vayssiere","year":"1997","journal-title":"Mol Endocrinol"},{"key":"10.1053\/jarr.2002.34845_NEWBIB22","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1126\/science.3283939","article-title":"The steroid and thyroid hormone receptor superfamily","volume":"240","author":"Evans","year":"1989","journal-title":"Science"},{"key":"10.1053\/jarr.2002.34845_NEWBIB23","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1210\/mend.11.8.9951","article-title":"Structural organization of the human vitamin D receptor chromosomal gene and its promoter","volume":"11","author":"Miyamoto","year":"1997","journal-title":"Mol Endocrinol"},{"key":"10.1053\/jarr.2002.34845_NEWBIB24","first-page":"156","article-title":"The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets","volume":"20","author":"Malloy","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1053\/jarr.2002.34845_NEWBIB25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0960-0760(99)00042-4","article-title":"T In vivo function of VDR in gene expression-VDR knock-out mice","volume":"69","author":"Kato","year":"1999","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1053\/jarr.2002.34845_NEWBIB26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1023\/A:1010062929140","article-title":"Molecular nature of the vitamin D receptor and its role in regulation of gene expression","volume":"2","author":"Jurutka","year":"2001","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1053\/jarr.2002.34845_NEWBIB27","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1128\/MCB.19.6.4191","article-title":"A two-hit mechanism for vitamin D3-mediated transcriptional repression of the granulocyte-macrophage colony-stimulating factor gene: Vitamin D receptor competes for DNA binding with NFAT1 and stabilizes c-Jun","volume":"19","author":"Towers","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1053\/jarr.2002.34845_NEWBIB28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0378-1119(00)00052-4","article-title":"Mechanisms of gene regulation by vitamin D(3) receptor: A network of coactivator interactions","volume":"246","author":"Rachez","year":"2000","journal-title":"Gene"},{"key":"10.1053\/jarr.2002.34845_NEWBIB29","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1128\/MCB.20.8.2718-2726.2000","article-title":"The DRIP complex and SRC-1\/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes","volume":"20","author":"Rachez","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1053\/jarr.2002.34845_NEWBIB30","first-page":"2211","article-title":"The vitamin and the hormone","volume":"33","author":"DeLuca","year":"1974","journal-title":"Fed Proc"},{"key":"10.1053\/jarr.2002.34845_NEWBIB31","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1073\/pnas.78.8.4990","article-title":"Differentiation of mouse myeloid leukemia cells induced by 1alpha,25-dihydroxyvitamin D3","volume":"78","author":"Abe","year":"1981","journal-title":"Proc Nat Acad Sci U S A"},{"key":"10.1053\/jarr.2002.34845_NEWBIB32","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1210\/endo-113-6-1950","article-title":"Regulation of terminal differentiation of cultured mouse epidermal cells by 1alpha,25-dihydroxyvitamin D3","volume":"113","author":"Hosomi","year":"1983","journal-title":"Endocrinology"},{"key":"10.1053\/jarr.2002.34845_NEWBIB33","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1096\/fj.01-0433rev","article-title":"Its role and uses in immunology","volume":"15","author":"DeLuca","year":"2001","journal-title":"FASEB J"},{"key":"10.1053\/jarr.2002.34845_NEWBIB34","first-page":"463","article-title":"Other vitamin D tissues: Vitamin D action in cardiovascular tissue, and muscle, endocrine and reproductive tissues, and liver and lung","author":"Walters","year":"1997"},{"key":"10.1053\/jarr.2002.34845_NEWBIB35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1749-6632.1992.tb17089.x","article-title":"New concepts of vitamin D functions","volume":"669","author":"DeLuca","year":"1992","journal-title":"Ann N Y Acad Sci"},{"key":"10.1053\/jarr.2002.34845_NEWBIB36","first-page":"1089","article-title":"Vitamin D, anticancer and differentiation","author":"van Leeuwen","year":"1997"},{"key":"10.1053\/jarr.2002.34845_NEWBIB37","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.V981427","article-title":"19-Nor-1alpha,25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone inpatients on hemodialysis","volume":"9","author":"Martin","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/jarr.2002.34845_NEWBIB38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ndt\/11.supp3.121","article-title":"Effect of 22-oxacalcitriol on hyperparathyroidism of dialysis patents: Results of a preliminary study","volume":"11","author":"Kurokawa","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2002.34845_NEWBIB39","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ki.1997.39","article-title":"Effective suppression of parathyroid hormone by 1 alpha-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism","volume":"51","author":"Tan","year":"1997","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2002.34845_NEWBIB40","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1001\/archderm.1989.01670240047011","article-title":"Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotrial (MC903)","volume":"125","author":"Kragballe","year":"1989","journal-title":"Arch Dematol"},{"key":"10.1053\/jarr.2002.34845_NEWBIB41","doi-asserted-by":"crossref","first-page":"10551","DOI":"10.1074\/jbc.270.18.10551","article-title":"Distinct conformational changes induced by 20-epi analogues of 1alpha, 25-dihydorxyvitamin D3 are associated with enhanced activation of the vitamin D receptor","volume":"270","author":"Peleg","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1053\/jarr.2002.34845_NEWBIB42","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1128\/MCB.19.2.1049","article-title":"Selective interaction of vitamin D receptor with transcriptional co-activators by a vitamin D analogue","volume":"19","author":"Takeyama","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1053\/jarr.2002.34845_NEWBIB43","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1210\/mend.12.4.0083","article-title":"Differential use of transcription activation function 2 domain of the vitamin D receptor by 1,25-dihydroxyvitamin D3 and its A ring-modified analogs","volume":"12","author":"Peleg","year":"1998","journal-title":"Mol Endocrinol"},{"key":"10.1053\/jarr.2002.34845_NEWBIB44","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1172\/JCI112714","article-title":"Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat","volume":"78","author":"Silver","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1053\/jarr.2002.34845_NEWBIB45","doi-asserted-by":"crossref","first-page":"8097","DOI":"10.1073\/pnas.89.17.8097","article-title":"Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3","volume":"89","author":"Demay","year":"1992","journal-title":"Proc Nat Acad Sci U S A"},{"key":"10.1053\/jarr.2002.34845_NEWBIB46","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/endo-128-4-1687","article-title":"On the mechanism for the selective action of vitamin D analogs","volume":"128","author":"Dusso","year":"1991","journal-title":"Endocrinol"},{"key":"10.1053\/jarr.2002.34845_NEWBIB47","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1097-2765(00)80413-X","article-title":"The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand","volume":"5","author":"Rochel","year":"2000","journal-title":"Mol Cell"},{"key":"10.1053\/jarr.2002.34845_NEWBIB48","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1073\/pnas.091018698","article-title":"Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands","volume":"98","author":"Tocchini-Valentini","year":"2001","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Advances in Renal Replacement Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107344490270037X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107344490270037X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T06:47:35Z","timestamp":1622098055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107344490270037X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["S107344490270037X"],"URL":"https:\/\/doi.org\/10.1053\/jarr.2002.34845","relation":{},"ISSN":["1073-4449"],"issn-type":[{"value":"1073-4449","type":"print"}],"subject":[],"published":{"date-parts":[[2002,7]]}}}